Why did ITRM's stock price hit a 52-week low?

Iterum Therapeutics' (ITRM) stock price hit a 52-week low of $0.62 on July 25, 2025. The decline in ITRM's stock price can be attributed to several factors: 1. **Financial Performance**: Iterum Therapeutics has reported a decrease in operating expenses to $4.9 million in Q3 2024 from $16.7 million in Q3 2023, with a net loss of $6.1 million. Despite this, the company maintains sufficient cash resources to fund operations into 2025. However, the financial performance has not met the expectations, which could have led to a decline in investor confidence. 2. **Regulatory Challenges**: The company is striving to regain compliance with Nasdaq Listing Rule 5550(b)(1) and has been granted a 180-day extension to do so. This indicates that the company is facing regulatory challenges, which could be a cause for concern among investors. In conclusion, the decline in Iterum Therapeutics' stock price to a 52-week low is likely a result of a combination of poor financial performance and regulatory challenges. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |ITRM|ITRM.O|Iterum Therapeutics|20240729|-5.6|186| |ITRM|ITRM.O|Iterum Therapeutics|20240730|0.8475|186| |ITRM|ITRM.O|Iterum Therapeutics|20240731|0.4202|186| |ITRM|ITRM.O|Iterum Therapeutics|20240801|-2.0921|186| |ITRM|ITRM.O|Iterum Therapeutics|20240802|2.5641|186| |ITRM|ITRM.O|Iterum Therapeutics|20240805|-5|186| |ITRM|ITRM.O|Iterum Therapeutics|20240806|0.8772|186| |ITRM|ITRM.O|Iterum Therapeutics|20240807|-4.3478|186| |ITRM|ITRM.O|Iterum Therapeutics|20240808|-3.6364|186| |ITRM|ITRM.O|Iterum Therapeutics|20240809|11.3208|186|